New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...

Researchers assess the adequacy of tissue ablation by a cooled laser therapy in patients with localized prostate cancer.

A supplement made from broccoli, green tea, and turmeric has slowed the rise of a prostate cancer blood marker in men monitored for early disease. That slowdown reframes how long some patients may ...

Timing and uptake of germline testing in patients with somatic BRCA1/2 pathogenic or likely pathogenic variants in solid tumors: A real-world study from community oncology practices. Identifying ...

It is difficult to escape a genitourinary malignancies session at any major oncology meeting these days without hearing a proclamation that the technetium-99 (Tc99) bone scan is dead. The triumphant ...

A research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients after successful development of a new alpha-ray therapeutic agent ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

CIRT leads to temporary urinary function decline, normalizing within three months and stable for five years. Prostate volume decreases significantly without ADT, remaining reduced for five years. T ...